Ilise L. Feitshans, J.D., Sc.M.

Ms. Feitshans is Adjunct Associate Professor, George Washington University School of Public Health and Health Services, Washington D.C., and Legal Advisor, WHO/RAMS Committee of Experts on Reproductive Health at Work. She reports no conflict of interest.

Release Date: 04/29/2003
Termination Date: 04/29/2006

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Discuss implementation of new 2003 HIPAA regulations for medical privacy
• Discuss the significance of preventing unauthorized disclosure of personal medical information
• Describe at least 5 basic components of an in-house compliance system that secures protected health information (PHI).

 

The information contained and displayed in this communication and within this Web site is provided solely for educational and discussion purposes. It does not constitute legal advice. No attorney-client relationship is formed by the transmission or receipt of this communication. No warranty, express or implied, is being offered. The actual law in the member-subscriber's jurisdiction may differ from that which is described in this communication. The member-subscriber should seek legal advice from his or her attorney on any matters related to the subject matter of this communication.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

Health Law Disclaimer

The information contained and displayed in this communication and within this Web site is provided solely for educational and discussion purposes. It does not constitute legal advice. No attorney-client relationship is formed by the transmission or receipt of this communication. No warranty, express or implied, is being offered. The actual law in the member-subscriber's jurisdiction may differ from that which is described in this communication. The member-subscriber should seek legal advice from his or her attorney on any matters related to the subject matter of this communication.

 

Please click below to accept the terms of this CME activity